Insights

Amended FRE 702 on Expert Testimony Effective December 1, 2023

FTC Challenges to Orange Book Listings: Considerations for Patent Holders

Strategic Use of Evidence at the Patent Trial and Appeal Board

Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

ITC Monthly Wrap-Up: November 2023

Minnesota Patent Litigation Wrap-Up: Q3 2023